Edition:
United Kingdom

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,045
52-wk High
$4.54
52-wk Low
$1.43

Chart for

About

Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases. The Company is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in... (more)

Overall

Beta: 1.24
Market Cap(Mil.): $55.71
Shares Outstanding(Mil.): 15.39
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Evoke Pharma reports Q3 loss per share $0.34

* Evoke Pharma reports third quarter 2017 results and highlights

14 Nov 2017

BRIEF-Evoke Pharma signs commercial agreement with Thermo Fisher Scientific

* Announced selection of Patheon division of Thermo Fisher Scientific as commercial manufacturing partner for Gimoti​

09 Nov 2017

BRIEF-Evoke Pharma reports positive topline results from comparative exposure pharmacokinetic study for gimoti

* Evoke Pharma announces positive topline results from comparative exposure pharmacokinetic study for gimoti™

23 Oct 2017

BRIEF-Evoke pharma completes dosing for Gimoti™comparative exposure Pharmacokinetic study

* Evoke pharma completes dosing for Gimoti™ comparative exposure Pharmacokinetic study

12 Sep 2017

BRIEF-Evoke Pharma reports Q2 loss per share $0.11

* Evoke Pharma reports second quarter 2017 results and highlights

14 Aug 2017

BRIEF-Evoke pharma inc initiates comparative exposure Pharmacokinetic Study for Gimoti

* Evoke Pharma Inc - ‍initiation of its comparative exposure Pharmacokinetic trial for Gimoti​

14 Aug 2017

Competitors

Earnings vs. Estimates